Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC069499.1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | AC096949.1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
mRNA | ACADM | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ACAN | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |
mRNA | ACAT2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
mRNA | ACBD4 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
mRNA | ACO1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | ACOT8 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
mRNA | ACRBP | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
mRNA | ACSF2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |